Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia

Detalhes bibliográficos
Autor(a) principal: Souza,Patrícia Medeiros de
Data de Publicação: 2018
Outros Autores: Kusano,Liana Tieko Evangelista, Neto,Leopoldo Luiz dos Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Geriatrics, Gerontology and Aging (Online)
Texto Completo: https://ggaging.com/details/479
Resumo: <p><b>BACKGROUND:</b> Polypharmacy can be defined quantitatively or qualitatively. One of the concepts underlying the quantitative definition of polypharmacy is the use of two or more medications. The qualitative definition, in turn, takes into account the rationalization of pharmacotherapy.<br> <b>OBJECTIVES:</b> Based on these two concepts, this study aimed to determine the prevalence of polypharmacy in older adults with dementia and correlate it with sociodemographic, clinical, and pharmacological characteristics.<br> <b>METHODS:</b> A cross-sectional study was conducted in a center of excellence for dementia care in the Federal District, including 97 older adults with a diagnosis of Alzheimer dementia. Prevalence rates were determined for quantitative and qualitative polypharmacy. The presence of polypharmacy was correlated with the characteristics of the sample by univariate analysis. Descriptive statistics were calculated for all dependent and independent variables. The correlation between secondary variables and polypharmacy was determined by prevalence ratio. Univariate analysis was performed using the following statistical tests: Pearson’s &#967;<sup>2</sup> test, Kruskal-Wallis test, and Wilcoxon-Mann-Whitney (WMW) test.<br> <b>RESULTS:</b> The prevalence of quantitative polypharmacy was 92.8%, of which 37.2% were characterized as minor, 25.8% as moderate, and 29.8% as major. The prevalence of qualitative polypharmacy was 49.5%. Sociodemographic and clinical characteristics were not associated with quantitative or qualitative polypharmacy.<br> <b>CONCLUSION:</b> Both quantitative and qualitative polypharmacy were highly prevalent among older adults with dementia. The delivery of multidisciplinary care to older outpatients through a methodology that identifies and characterizes polypharmacy both quantitatively and qualitatively seems to be a useful tool to promote the rational use of medications.</p>
id SBGG_e6303f1aeb8eaf6a2df25d84ad998b92
oai_identifier_str oai:ggaging.com:479
network_acronym_str SBGG
network_name_str Geriatrics, Gerontology and Aging (Online)
repository_id_str
spelling Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementiaaged health of the aged Alzheimer disease.<p><b>BACKGROUND:</b> Polypharmacy can be defined quantitatively or qualitatively. One of the concepts underlying the quantitative definition of polypharmacy is the use of two or more medications. The qualitative definition, in turn, takes into account the rationalization of pharmacotherapy.<br> <b>OBJECTIVES:</b> Based on these two concepts, this study aimed to determine the prevalence of polypharmacy in older adults with dementia and correlate it with sociodemographic, clinical, and pharmacological characteristics.<br> <b>METHODS:</b> A cross-sectional study was conducted in a center of excellence for dementia care in the Federal District, including 97 older adults with a diagnosis of Alzheimer dementia. Prevalence rates were determined for quantitative and qualitative polypharmacy. The presence of polypharmacy was correlated with the characteristics of the sample by univariate analysis. Descriptive statistics were calculated for all dependent and independent variables. The correlation between secondary variables and polypharmacy was determined by prevalence ratio. Univariate analysis was performed using the following statistical tests: Pearson’s &#967;<sup>2</sup> test, Kruskal-Wallis test, and Wilcoxon-Mann-Whitney (WMW) test.<br> <b>RESULTS:</b> The prevalence of quantitative polypharmacy was 92.8%, of which 37.2% were characterized as minor, 25.8% as moderate, and 29.8% as major. The prevalence of qualitative polypharmacy was 49.5%. Sociodemographic and clinical characteristics were not associated with quantitative or qualitative polypharmacy.<br> <b>CONCLUSION:</b> Both quantitative and qualitative polypharmacy were highly prevalent among older adults with dementia. The delivery of multidisciplinary care to older outpatients through a methodology that identifies and characterizes polypharmacy both quantitatively and qualitatively seems to be a useful tool to promote the rational use of medications.</p>Sociedade Brasileira de Geriatria e Gerontologia2018-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttps://ggaging.com/details/479Geriatrics, Gerontology and Aging v.12 n.3 2018reponame:Geriatrics, Gerontology and Aging (Online)instname:Sociedade Brasileira de Geriatria e Gerontologiainstacron:SBGG10.5327/Z2447-211520181800036info:eu-repo/semantics/openAccess Souza,Patrícia Medeiros de Kusano,Liana Tieko Evangelista Neto,Leopoldo Luiz dos Santoseng2018-07-01T00:00:00Zoai:ggaging.com:479Revistahttp://sbgg.org.br/publicacoes-cientificas/revista-geriatria-gerontologia/ONGhttps://old.scielo.br/oai/scielo-oai.phpexecutiveditors@ggaging.com||nacional@sbgg.org.br2447-21232447-2115opendoar:2018-07-01T00:00Geriatrics, Gerontology and Aging (Online) - Sociedade Brasileira de Geriatria e Gerontologiafalse
dc.title.none.fl_str_mv Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
title Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
spellingShingle Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
Souza,Patrícia Medeiros de
aged
health of the aged
Alzheimer disease.
title_short Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
title_full Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
title_fullStr Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
title_full_unstemmed Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
title_sort Prevalence of quantitative and qualitative polypharmacy in older adults with Alzheimer dementia
author Souza,Patrícia Medeiros de
author_facet Souza,Patrícia Medeiros de
Kusano,Liana Tieko Evangelista
Neto,Leopoldo Luiz dos Santos
author_role author
author2 Kusano,Liana Tieko Evangelista
Neto,Leopoldo Luiz dos Santos
author2_role author
author
dc.contributor.author.fl_str_mv Souza,Patrícia Medeiros de
Kusano,Liana Tieko Evangelista
Neto,Leopoldo Luiz dos Santos
dc.subject.por.fl_str_mv aged
health of the aged
Alzheimer disease.
topic aged
health of the aged
Alzheimer disease.
description <p><b>BACKGROUND:</b> Polypharmacy can be defined quantitatively or qualitatively. One of the concepts underlying the quantitative definition of polypharmacy is the use of two or more medications. The qualitative definition, in turn, takes into account the rationalization of pharmacotherapy.<br> <b>OBJECTIVES:</b> Based on these two concepts, this study aimed to determine the prevalence of polypharmacy in older adults with dementia and correlate it with sociodemographic, clinical, and pharmacological characteristics.<br> <b>METHODS:</b> A cross-sectional study was conducted in a center of excellence for dementia care in the Federal District, including 97 older adults with a diagnosis of Alzheimer dementia. Prevalence rates were determined for quantitative and qualitative polypharmacy. The presence of polypharmacy was correlated with the characteristics of the sample by univariate analysis. Descriptive statistics were calculated for all dependent and independent variables. The correlation between secondary variables and polypharmacy was determined by prevalence ratio. Univariate analysis was performed using the following statistical tests: Pearson’s &#967;<sup>2</sup> test, Kruskal-Wallis test, and Wilcoxon-Mann-Whitney (WMW) test.<br> <b>RESULTS:</b> The prevalence of quantitative polypharmacy was 92.8%, of which 37.2% were characterized as minor, 25.8% as moderate, and 29.8% as major. The prevalence of qualitative polypharmacy was 49.5%. Sociodemographic and clinical characteristics were not associated with quantitative or qualitative polypharmacy.<br> <b>CONCLUSION:</b> Both quantitative and qualitative polypharmacy were highly prevalent among older adults with dementia. The delivery of multidisciplinary care to older outpatients through a methodology that identifies and characterizes polypharmacy both quantitatively and qualitatively seems to be a useful tool to promote the rational use of medications.</p>
publishDate 2018
dc.date.none.fl_str_mv 2018-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://ggaging.com/details/479
url https://ggaging.com/details/479
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5327/Z2447-211520181800036
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Geriatria e Gerontologia
publisher.none.fl_str_mv Sociedade Brasileira de Geriatria e Gerontologia
dc.source.none.fl_str_mv Geriatrics, Gerontology and Aging v.12 n.3 2018
reponame:Geriatrics, Gerontology and Aging (Online)
instname:Sociedade Brasileira de Geriatria e Gerontologia
instacron:SBGG
instname_str Sociedade Brasileira de Geriatria e Gerontologia
instacron_str SBGG
institution SBGG
reponame_str Geriatrics, Gerontology and Aging (Online)
collection Geriatrics, Gerontology and Aging (Online)
repository.name.fl_str_mv Geriatrics, Gerontology and Aging (Online) - Sociedade Brasileira de Geriatria e Gerontologia
repository.mail.fl_str_mv executiveditors@ggaging.com||nacional@sbgg.org.br
_version_ 1797174502134644737